EU AI Act: How pharma can dodge massive fines with smart R&D strategy

Updated as of: 22 August 2025
As pharma companies continue to prepare for the first comprehensive legal framework for AI to take full effect, legal experts reveal how a little-known R&D exemption could be the difference between compliance and crippling €35m fines.